Introduction
MemorabiliaHome > Memorabilia

Apr 17-20, 2012, taking part in The 67rd China International Medical Equipment Fair (CMEF) in Shenzhen

Apr 16-17, 2012, taking part in “2012 Heilongjiang clinical laboratory quality assessment summary of the General Assembly” in Haerbin.

Mar 31-Apr 1, 2012, WEGO Biotech held one seminar “Chinas first multi-wavelength automatic direct chemiluminescence analyzer to promote changes in the Clinical Laboratory Immunology” in Luoyang City, Henan.

Mar 28-29, 2012, taking part in “2012 annual meeting of of Jilin examination laboratory directors” in Changchun.

Mar 24-27, 2012, taking part in “2012 Shandong clinical laboratory quality assessment summary of the General Assembly” in Zibo ctiy.

Mar 19-23, 2012, taking part in “9th Clinical Laboratory Provider and Blood Transfusion Equipment Expo” in Rend star International Center in Changsha city.

Mar 19-21, 2012, taking part in “2012 Hainan clinical laboratory quality assessment summary of the General Assembly” in Haikou.

Feb 25-29, 2012, taking part in “2012 Jiangxi clinical laboratory quality assessment summary of the General Assembly” in Jingdezhen.

Feb 24-27, 2012, taking part in “2012 Guangxi clinical laboratory quality assessment summary of the General Assembly” in Nanning.

Oct 31-Nov 3, 2011, take part in 66rd China International Medical Equipment Fair (CMEF) in Fuzhou.

Oct 14, 2011, Chinas first multi-wavelength automatic direct chemiluminescence analyzer listing conference was held in Weihai.

May 19, 2011, borne by the Weihai WEGO Biotechnology Co., Ltd., the fully automated chemiluminescent determination of the major infectious diseases such as AIDS and viral hepatitis research and development technology platform project was included in the major infectious diseases major science and technology,receives funding support for 4.11 million yuan, the project has important practical significance for the major infectious diseases such as AIDS and viral hepatitis prevention. The success of this project included in the major projects of national science and technology, will greatly promote the raising the level of Weihai City of pharmaceutical research, and promote the pharmaceutical industry in Weihai City, to a new level.

April 2011, the automated chemiluminescence analyzer is listing. Product Registration No: Lu Food and Drug Administration mechanical (quasi-) word 2011 No. 2400107

February 2009, 36 conventional biochemical reagents Series costumes listed with reliable stability and accuracy of products

In 2008, HIV HIV, HCV and TP reagents (chemiluminescence method) with the high sensitivity and specificity are approved for listing, filling the gaps, improving infectious disease detection platform.

In 2008, hepatitis B five (chemiluminescence method) listing is permitted.

In 2008, seven of detection of thyroid function (chemiluminescence method) obtain the approval number.

November 25, 2008, HIV1 / 2 antibody diagnostic kits (chemiluminescence method) was awarded the second prize of Shandong Province market Technology Golden Bridge Award.

June 30, 2008, HCV antibody diagnostic kits (chemiluminescence method) independently developed by the company are awarded the Outstanding Achievement Award of technological innovation in Shandong Province.

June 30, 2008, HIV1 / 2 antibody diagnostic kits (chemiluminescence method) independently developed by the company won the second prize of Shandong Province outstanding achievements of technological innovation.

June 30, 2008, pre-S1 antigen diagnostic reagent kit (colloidal gold method) independently developed by the company won the third prize of the outstanding achievements of technological innovation in Shandong Province.

2008, issued of “Shandong Province high-tech enterprise by the Shandong Province Science and Technology Department.

In November 2007, hepatitis B five and hepatitis C (ELISA) are approved for listing

In October 2007, getting the GMP certification.

In 2006, the company get medical device production and operation permit

In 2005, the company set up and achieved the pharmaceutical production license


© Weigao group 2020